Wall Street Zen Upgrades Nukkleus (NASDAQ:DFNS) to Sell

Nukkleus (NASDAQ:DFNSGet Free Report) was upgraded by Wall Street Zen to a “sell” rating in a report released on Saturday.

DFNS has been the subject of several other reports. Noble Financial raised Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. Weiss Ratings lowered Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Nukkleus presently has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Report on Nukkleus

Nukkleus Price Performance

Nukkleus stock opened at $4.35 on Friday. Nukkleus has a fifty-two week low of $3.70 and a fifty-two week high of $1,948.75. The stock has a market cap of $3.31 million, a PE ratio of -1.48 and a beta of -5.82. The firm’s 50-day simple moving average is $27.12 and its 200 day simple moving average is $139.72. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.21 and a current ratio of 0.25.

Nukkleus (NASDAQ:DFNSGet Free Report) last posted its quarterly earnings data on Wednesday, May 20th. The company reported ($142.50) EPS for the quarter. The business had revenue of $3.65 million for the quarter. Research analysts predict that Nukkleus will post -63.98 EPS for the current fiscal year.

Institutional Trading of Nukkleus

Several hedge funds have recently added to or reduced their stakes in DFNS. GM Advisory Group LLC purchased a new position in Nukkleus in the fourth quarter valued at about $56,000. BNP Paribas Financial Markets bought a new position in shares of Nukkleus during the 2nd quarter valued at approximately $56,000. Price T Rowe Associates Inc. MD purchased a new stake in shares of Nukkleus during the 4th quarter worth approximately $57,000. Millennium Management LLC purchased a new stake in shares of Nukkleus during the 4th quarter worth approximately $60,000. Finally, State Street Corp increased its stake in shares of Nukkleus by 70.7% during the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after purchasing an additional 7,400 shares during the last quarter. Institutional investors own 12.47% of the company’s stock.

Nukkleus Company Profile

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

Recommended Stories

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.